Resume

WADA invites researchers, with expertise in the field of hematology, to apply for funding to undertake research projects aimed at delivering an anti-doping method that detects autologous blood transfusion (ABT).

At a minimum, the method should:

- be applicable for blood and/or urine;

- be sensitive enough to detect ABT in a proportion of less than 150 mL (or 4%) of transfused, refrigerated or frozen, red blood cells (RBCs) with a window of detection of at least 24/36 hours;

- have a degree of specificity of 99.99% or above;

- be transferrable to WADA-accredited laboratories for routine anti-doping testing.

Funding

Funding will be provided through WADA’s Research Program.

The Agency anticipates funding two to three grants for the initial proof of concept phase.

The funding would be up to:

- USD 300,000 per project for initial proof of concept

- USD 300,000 for validation of proof of concept

- USD 200,000 for transfer to accredited laboratories

- USD 200,000 for routine implementation in accredited laboratories

Any requests for a higher level of funding should be discussed with WADA’s Science Department for which contact information is provided below.

How to apply

https://grants.wada-ama.org/science/home?l=en

In case of interest, please contact with FSJD Research's Foundation no later than January 24th.